Current scientific evidence is sufficient to link GLP-1 drugs to NAION

A cohort study and EMA safety signal suggest a link, but AAO and NANOS note mixed findings in their May 2026 consensus statement.

From the articleGLP-1s and NAION: Do Patients Need a Warning?Also in Semaglutide, Tirzepatide Linked to Small Increase in Eye Disorder Risk | AJMC